Evidence map›Paper›PMID 33254500›Full record

ArticleMedical hypotheses2020

Bone biology and COVID-19 infection: Is ACE2 a potential influence factor?

Huaqiang Tao, Jiaxiang Bai, Weicheng Zhang, Kai Zheng, Pengfei Guan, Gaoran Ge, Meng Li, Dechun Geng

Open access · greenAbstract read
In one paragraph

Article in Medical hypotheses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Avascular Necrosis of the Hip after the COVID-19 Pandemic.Journal of pharmacy & bioallied sciences · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Huaqiang TaoDepartment of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Jiaxiang BaiDepartment of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Weicheng ZhangDepartment of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Kai ZhengDepartment of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Pengfei GuanENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
Gaoran GeDepartment of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Meng LiDepartment of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Dechun GengDepartment of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou 215000, China. Electronic address: szgengdc@suda.edu.cn.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CNEye & ENT Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) has posed a severe threat to global health management system since it has been detected in the human body. This pandemic was prompted by severe acute respiratory syndrome coronaviruses 2 (SARS-CoV-2) and rapidly developed into a public emergency with an alarming increase in cases and deaths. The increasing explorations to SARS-CoV-2 infection guide us to consider whether bone lesion is followed by this pathologic process. We especially focus on the underlying pathobiology that SARS-CoV-2 possibly mediated in bone remodeling and analyze the association of bone destruction with ACE2 in COVID-19 incidence, for preferable understanding the pathogenesis and providing necessary clinical management in orthopedics.

Indexed as

Angiotensin-Converting Enzyme 2AnimalsAntiviral AgentsBone and BonesBone DiseasesCOVID-19HumansImmune SystemMiceModels, TheoreticalMusclesOrthopedicsSARS-CoV-2ACE2 protein, humanAce2 protein, mouseAngiotensin-Converting Enzyme 2Antiviral AgentsACE2Bone lesionCOVID-19SARS-COV-2

Identifiers

PMID33254500
PMCPMC7416709
OpenAlexW3048160789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.